acetylcysteine has been researched along with Hallucinations in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Berk, M; Brown, E; Dean, OM; Dipnall, JF; Krägeloh, CU; McNamara, RK; Medvedev, ON; Narayanan, A; Sandham, MH; Siegert, RJ; Sumich, A | 1 |
Chan, MH; Chen, HH; Chiang, CC; Chiu, HY; Lee, MY | 1 |
2 other study(ies) available for acetylcysteine and Hallucinations
Article | Year |
---|---|
A novel way to quantify schizophrenia symptoms in clinical trials.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Antipsychotic Agents; Attention; Clinical Trials as Topic; Delusions; Female; Free Radical Scavengers; Guilt; Hallucinations; Humans; Male; Middle Aged; Mood Disorders; Patient Outcome Assessment; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Young Adult | 2021 |
N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
Topics: Acetylcysteine; Action Potentials; Amino Acids; Amphetamines; Animals; Benzoates; Bicuculline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Early Growth Response Protein 2; Excitatory Amino Acid Antagonists; Free Radical Scavengers; GABA-A Receptor Antagonists; Glycine; Hallucinations; Hallucinogens; Male; Mice; Proto-Oncogene Proteins c-fos; Receptors, Metabotropic Glutamate; Xanthenes | 2014 |